PaySign, Inc. provided earnings guidance for the year 2022. For the full year 2022, the company expects total revenue to be in the range of $35.25 million to $38.35 million, reflecting growth of 20% to 30%, with plasma making up approximately 90% of total revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | +4.16% |
|
+2.04% | +43.21% |
05-13 | Barrington Raises Price Target on Paysign to $7 From $5.50, Keeps Outperform Rating | MT |
05-08 | Maxim Adjusts Paysign's Price Target to $6 From $5.50, Keeps Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.21% | 212M | |
+12.23% | 87.23B | |
-4.95% | 61.06B | |
-18.05% | 39.33B | |
-25.34% | 24.2B | |
-4.73% | 18.92B | |
-26.19% | 10.75B | |
-21.51% | 8.88B | |
-22.71% | 7.95B | |
-10.34% | 7.31B |
- Stock Market
- Equities
- PAYS Stock
- News Paysign, Inc.
- PaySign, Inc. Provides Earnings Guidance for the Year 2022